Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Drilling at Pt. Leamington unveils a copper-rich extension, targeting near-surface high-grade zones (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Poolbeg Pharma PLC (PK) POLBF

Healthcare Biotechnology
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (PINL:POLBF)

Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

ACCESS Newswire July 26, 2024

Poolbeg Pharma PLC Announces Change of Registered Address

ACCESS Newswire July 2, 2024

Poolbeg Pharma PLC Announces Result of AGM

ACCESS Newswire June 17, 2024

Poolbeg Pharma PLC Announces Annual Report & AGM Notice

ACCESS Newswire May 9, 2024

Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA

ACCESS Newswire May 1, 2024

Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023

ACCESS Newswire April 30, 2024

Poolbeg Pharma PLC Announces Appointment of Joint Broker

ACCESS Newswire April 30, 2024

Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate

ACCESS Newswire April 30, 2024

Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings

ACCESS Newswire April 29, 2024
View More News ››

Opinion & Analysis (PINL:POLBF)

No current opinion is available.
View More Opinion ››

Bullboard Posts (PINL:POLBF)

Be the first to post on this bullboard.

Nine Mile Metals Ltd.

Nine Mile Metals Ltd.

Nine Mile Metals Ltd. engages in the acquisition, development, and exploration of mineral properties in Canada. The company ...
View More »

Podcasts